In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model
We characterized in vivo a functional superparamagnetic iron-oxide magnetic resonance contrast agent that shortens the T2 relaxation time in magnetic resonance imaging (MRI) of prostate cancer xenografts. The agent was developed by conjugating Molday ION™ carboxyl-6 (MIC6), with a deimmunized mouse...
Saved in:
Main Authors: | Christopher Brian Abraham, Prashant Jani, Roxanne Turuba, Michael Campbell, Ingeborg Zehbe, Laura Curiel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Nanotechnology |
Online Access: | http://dx.doi.org/10.1155/2017/8424686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Magnetic Resonance Imaging of Contrast-Induced Acute Renal Injury and Related Pathological Alterations In Vivo
by: Yanfei Li, et al.
Published: (2022-01-01) -
Reactive Oxygen Species Generation in Human Cells by a Novel Magnetic Resonance Imaging Contrast Agent
by: Li Wang, et al.
Published: (2018-01-01) -
Automatic Quantification of Atherosclerosis in Contrast-Enhanced MicroCT Scans of Mouse Aortas Ex Vivo
by: Vincent A. Stadelmann, et al.
Published: (2021-01-01) -
Solvothermal synthesis of polyvinyl pyrrolidone encapsulated, amine-functionalized copper ferrite and its use as a magnetic resonance imaging contrast agent.
by: Fatemeh Heydari, et al.
Published: (2025-01-01) -
From brain to endocast: Contrasting Magnetic Resonance Imagining and Computerized Tomography in paleoneurology
by: Riccardo Frittitta, et al.
Published: (2025-01-01)